Targeting CXCR4 abrogates resistance to trastuzumab by blocking cell cycle progression and synergizes with docetaxel in breast cancer treatment

Shuying Liu, Shelly M. Xie, Wenbin Liu, Mihai Gagea, Ariella B. Hanker, Nguyen Nguyen, Akshara Singareeka Raghavendra, Gloria Yang-Kolodji, Fuliang Chu, Sattva S. Neelapu, Adriano Marchese, Samir Hanash, Johann Zimmermann, Carlos L. Arteaga, Debasish Tripathy

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Targeting CXCR4 abrogates resistance to trastuzumab by blocking cell cycle progression and synergizes with docetaxel in breast cancer treatment'. Together they form a unique fingerprint.

Medicine & Life Sciences